SEC Form 4 · accession 0001209191-18-020896
AGIOS PHARMACEUTICALS, INC. · AGIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Scadden
Director
Period of report
Mar 16, 2018
Accepted (ET)
Mar 20, 2018 · 4:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001439222
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Mar 16, 2018 | P | 200 | $83.44 | A | 571 | D |
Table II — derivative securities
No Table II lines on this filing.